Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Capital Expenditures (2024)

Updated

Belite Bio's Capital Expenditures came in at -$71,000 for FY2025, compared with -$116,000 in FY2024.

Analysis

Belite Bio (BLTE) Capital Expenditures (2024) Analysis & Trends

Going back to FY2020, Belite Bio's Capital Expenditures data covers 6 years.

  • The five-year range for annual Capital Expenditures is -$394,000 (FY2022) to -$63,000 (FY2023).
  • Per Business Quant, earlier years put Capital Expenditures at -$116,000 in FY2024, -$63,000 in FY2023, -$394,000 in FY2022 and -$74,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Belite Bio 6.16 Bn 6.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 232,000.00
API Access

Belite Bio Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BLTE&period=max&api_key=YOUR_API_KEY